These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 28385948)

  • 41. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
    Park SJ; Milano CA; Tatooles AJ; Rogers JG; Adamson RM; Steidley DE; Ewald GA; Sundareswaran KS; Farrar DJ; Slaughter MS;
    Circ Heart Fail; 2012 Mar; 5(2):241-8. PubMed ID: 22282104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.
    Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 44. International Normalized Ratio Test Frequency in Left Ventricular Assist Device Patients Affects Anticoagulation Quality and Adverse Events.
    Schlöglhofer T; Zapusek L; Wiedemann D; Riebandt J; Wittmann F; Dimitrov K; Angleitner P; Haberl L; Laufer G; Moscato F; Zimpfer D; Schima H
    ASAIO J; 2021 Feb; 67(2):157-162. PubMed ID: 32501824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
    Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two year adverse outcomes of the magnetic levitated centrifugal continuous flow circulatory pump versus the axial continuous-flow pump for advanced heart failure: A systematic review and meta-analysis of randomized controlled trials.
    Tang B; Yang H
    Medicine (Baltimore); 2020 Feb; 99(9):e19393. PubMed ID: 32118791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
    Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
    ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.
    Frazier OH; Rose EA; Oz MC; Dembitsky W; McCarthy P; Radovancevic B; Poirier VL; Dasse KA;
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1186-95. PubMed ID: 11726895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
    Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
    J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Device exchange from HeartMate II to HeartMate 3 left ventricular assist device.
    Takeda K; Takayama H; Sanchez J; Cevasco M; Yuzefpolskaya M; Colombo PC; Naka Y
    Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):430-433. PubMed ID: 31143932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
    John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry.
    Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto J; Morshuis M; Chuang J; Damme L; Zimpfer D; Garbade J
    Eur Heart J; 2018 Oct; 39(37):3454-3460. PubMed ID: 30165521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.
    Rogers JG; Pagani FD; Tatooles AJ; Bhat G; Slaughter MS; Birks EJ; Boyce SW; Najjar SS; Jeevanandam V; Anderson AS; Gregoric ID; Mallidi H; Leadley K; Aaronson KD; Frazier OH; Milano CA
    N Engl J Med; 2017 Feb; 376(5):451-460. PubMed ID: 28146651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One-year outcomes with the HeartMate 3 left ventricular assist device.
    Hanke JS; Dogan G; Zoch A; Ricklefs M; Wert L; Feldmann C; Bara C; Shrestha M; Tillmanns J; Kempf T; Bauersachs J; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):662-669. PubMed ID: 29525258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
    Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
    J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices.
    Imamura T; Narang N; Kim G; Raikhelkar J; Chung B; Nguyen A; Holzhauser L; Rodgers D; Kalantari S; Smith B; Ota T; Song T; Juricek C; Burkhoff D; Jeevanandam V; Sayer G; Uriel N
    J Am Heart Assoc; 2020 Apr; 9(7):e014801. PubMed ID: 32223394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®.
    Schramm R; Zittermann A; Morshuis M; Schoenbrodt M; von Roessing E; von Dossow V; Koster A; Fox H; Hakim-Meibodi K; Gummert JF
    ESC Heart Fail; 2020 Jun; 7(3):908-914. PubMed ID: 32190985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events.
    Imamura T; Nguyen A; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Juricek C; Rodgers D; Ota T; Song T; Jeevanandam V; Sayer G; Uriel N
    Eur J Heart Fail; 2019 May; 21(5):655-662. PubMed ID: 30592363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.